Improved survival in metastatic breast cancer 1985–2016

M Sundquist, L Brudin, G Tejler - The Breast, 2017 - Elsevier
Purpose In the last 25 years new treatment options in breast cancer have evolved. We
wanted to determine whether the survival of; patients with metastatic breast cancer have …
被引用次数：204 相关文章
[PDF] academia.edu

[PDF][PDF] Improved survival in metastatic breast cancer 1985e2016

M Sundquist, L Brudin, G Tejler - The Breast, 2017 - academia.edu
abstract Purpose: In the last 25 years new treatment options in breast cancer have evolved.
We wanted to determine whether the survival of; patients with metastatic breast cancer have …

Improved survival in metastatic breast cancer 1985–2016

M Sundquist, L Brudin, G Tejler - The Breast, 2017 - thebreastonline.com
Purpose In the last 25 years new treatment options in breast cancer have evolved. We
wanted to determine whether the survival of; patients with metastatic breast cancer have …

Improved survival in metastatic breast cancer 1985-2016.

M Sundquist, L Brudin, G Tejler - Breast (Edinburgh, Scotland), 2016 - europepmc.org
Purpose In the last 25 years new treatment options in breast cancer have evolved. We
wanted to determine whether the survival of; patients with metastatic breast cancer have …

Improved survival in metastatic breast cancer 1985–2016

M Sundquist, L Brudin, G Tejler - The Breast, 2017 - infona.pl
In the last 25 years new treatment options in breast cancer have evolved. We wanted to
determine whether the survival of; patients with metastatic breast cancer have improved …

[引用][C] Improved survival in metastatic breast cancer 1985–2016

M Sundquist, L Brudin, G Tejler - The Breast, 2017 - cir.nii.ac.jp
Improved survival in metastatic breast cancer 1985–2016 | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Improved survival in metastatic breast cancer 1985-2016

M Sundquist, L Brudin, G Tejler - Breast (Edinburgh …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose In the last 25 years new treatment options in breast cancer have evolved. We
wanted to determine whether the survival of; patients with metastatic breast cancer have …